<?xml version="1.0" encoding="UTF-8"?>
		<www.wjpsonline.org>
		<Title>A Review on India's biotechnology patenting regulations and challenges</Title>
		<Author>Meghna Tribhuwan, Dr. Shaikh Anisur Rahaman, Nikhil Vilas Tribhuwan</Author>
		<Volume>07</Volume>
		<Issue>09</Issue>
		<Abstract>An inventor who obtains a patent is given the sole authority to commercialise their idea for a 20year term and to safeguard it openly and without restriction With its significant economic worth a patent may be regarded as one of the most significant forms of IP rights The rules governing patents have a long history and have changed throughout time in response to societal needs the rate of invention and the intricacy of such advances The Patent Act 1970 and its 2005 and 2006 amendments known collectively as the Patents Amendment Act govern patent law in India For many academics biotechnology has grown to be an essential tool and the innovations it has inspired In addition to inspiring the development of several innovators and playing a significant part in enhancing the countrys health biotechnology has emerged as a valuable instrument for many researchers The preservation of these inventors rights becomes inappropriate therefore several biotechnological innovations including drugs microbes and transgenic animals have been awarded patent protection globally This essay seeks to evaluate Indian patent law with a particular emphasis on how it affects biotechnological inventions It sheds light on the patent rights of transgenic animals microorganisms and pharmaceuticals as well as how compulsory licensing prevents the misuse of patent law </Abstract>
		<permissions>
<copyright-statement>Copyright (c) World Journal of Pharmaceutical Seiences. All rights reserved</copyright-statement>
<copyright-year>2026</copyright-year>
</permissions>
		</www.wjpsonline.org>
		